Endocrine Unit and Diabetes Centre, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Department of Pediatric Oncology, Ippokratio General Hospital, Thessaloniki, Greece.
Endocrine. 2023 Nov;82(2):250-262. doi: 10.1007/s12020-023-03423-6. Epub 2023 Jun 22.
To investigate whether maternal cigarette smoking during pregnancy is a risk factor for developing GDM.
MEDLINE, Scopus, CENTRAL and Google Scholar databases were searched from inception to December 2022 to identify eligible original articles. A systematic review and meta-analysis (weighted data, random-effects model) were performed. The primary outcome was the development of GDM in pregnant women. The results were expressed as odds ratios (OR) with 95% confidence interval (CI) (inverse variance method). Subgroup analysis was planned according to the maternal smoking status and GDM diagnostic criteria. Statistical heterogeneity was checked with the Chi-squared (Chi) test and the I index was used to quantify it. The studies were evaluated for publication bias.
Thirty-five studies, including 23,849,696 pregnant women, met the inclusion criteria. The pooled OR of smoking during pregnancy compared with non-smoking (never smokers and former smokers) was 1.06 (95% CI 0.95-1.19), p = 0.30; I = 90%; Chi = 344; df=34; p < 0.001. Subgroup analysis was performed according to the two-step Carpenter-Coustan diagnostic criteria, due to the high heterogeneity among the other applied methods. The pooled OR for the Carpenter-Coustan subgroup was 1.19 (95% CI 0.95-1.49), p = 0.12; I = 63%; Chi = 27; df=10; p < 0.002. Further subgroup analysis according to maternal smoking status was not performed due to missing data.
There is no evidence to support an association between maternal cigarette smoking during pregnancy and the risk for GDM. Universally accepted diagnostic criteria for GDM must be adopted to reduce heterogeneity and clarify the association between smoking and GDM.
探讨孕期母体吸烟是否是妊娠期糖尿病(GDM)发生的危险因素。
从建库至 2022 年 12 月,检索 MEDLINE、Scopus、CENTRAL 和 Google Scholar 数据库,以识别合格的原始文章。进行系统评价和荟萃分析(加权数据,随机效应模型)。主要结局为孕妇发生 GDM。结果表示为比值比(OR)及其 95%置信区间(CI)(逆方差法)。根据母体吸烟状况和 GDM 诊断标准进行亚组分析。使用 Chi-squared(Chi)检验检查统计异质性,并使用 I 指数对其进行量化。评估研究的发表偏倚。
符合纳入标准的 35 项研究共纳入 23849696 名孕妇。与不吸烟(从不吸烟者和前吸烟者)相比,孕期吸烟的合并 OR 为 1.06(95%CI 0.95-1.19),p=0.30;I=90%;Chi=344;df=34;p<0.001。由于其他应用方法之间存在高度异质性,因此根据两步 Carpenter-Coustan 诊断标准进行了亚组分析。Carpenter-Coustan 亚组的合并 OR 为 1.19(95%CI 0.95-1.49),p=0.12;I=63%;Chi=27;df=10;p<0.002。由于缺少数据,没有进一步根据母体吸烟状况进行亚组分析。
目前尚无证据支持孕期母体吸烟与 GDM 风险之间存在关联。必须采用普遍接受的 GDM 诊断标准,以减少异质性并阐明吸烟与 GDM 之间的关系。